Stock ROVI LABORATORIOS FARMACEUTICOS ROVI, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Laboratorios Farmaceuticos Rovi, S.A.

Equities

ROVI

ES0157261019

Market Closed - BME
Other stock markets
 11:35:16 2024-06-12 am EDT 		Pre-market 02:51:50 am
88.15 EUR +0.40% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. 88.12 -0.03%
May. 08 Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment MT

Evolution of the average Target Price on Laboratorios Farmaceuticos Rovi, S.A.

Price target over the last 5 years

History of analyst recommendation changes

b2b1b50f.xxgvEYHnZac376l-rLqPR2ui7J8PKzXTCd3cKNoVy9I.jmFXete-CM9h3Zow5-zLajyahsp6fGe-TeWdeOhE-oqLWn9w1ddSwwW9mQ~4a5d65996432bd642d7619551f570287

Analyst Recommendations on Laboratorios Farmaceuticos Rovi, S.A.

Spain's Rovi raises guidance after 2021 profit jumped 151% RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
88.15 EUR
Average target price
89.44 EUR
Spread / Average Target
+1.46%
High Price Target
100.5 EUR
Spread / Highest target
+14.01%
Low Price Target
68 EUR
Spread / Lowest Target
-22.86%

Consensus detail

Consensus revision (last 18 months)

Ratings for Laboratorios Farmaceuticos Rovi, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. Consensus Laboratorios Farmaceuticos Rovi, S.A.